Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril vs Eplerenone vs Combination in Diabetic Nephropathy
NCT04143412Phase 2Unknown
- Sponsor
- Beni Suef University
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of eplerenone in diabetic nephropathy (DN) (3 arms), sponsored by Beni Suef University. Primary endpoint: Urinary albumin/creatinine ratio at 24 weeks. Status: unknown.
02
Drugs
eplerenone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT04143412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143412.